Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05769816Phase 2Recruiting
Phase 2 trial in Chronic Hepatitis B (CHB) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Serum Hepatitis B surface antigen, Serum Hepatitis B Virus DNA and 1 more. Started Oct 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05769816.